See also this year's filing and all EDGAR filings for this company.
PDF Report 0001094038_2023_Marker_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001094038, Marker Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 16,619,255 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 17,802,929 |
4 | LiabilitiesCurrent | 7,781,809 |
5 | LiabilitiesNoncurrent | 7,039,338 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 12,820,004 |
9 | ResearchAndDevelopmentExpense | 26,139,323 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 9,013,544 |
12 | remainder_NetIncome | 15,089 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 34,422,184 |
1 | Liabilities | 14,821,147 |
2 | Expenses | 38,959,327 |
3 | Revenues | 9,013,544 |
4 | StockholdersEquity | 19,601,037 |
5 | NetIncome | -29,930,694 |
6 | ComprehensiveNetIncome | -29,930,694 |
7 | BaseVar | 48,615,646 |
8 | EconomicCapitalRatio | 0.154 |